Alumis ALMS
NASDAQ ALMS
$7.29 +0.13 (+1.82%)
At close: Sep 29, 2026 · 4:00 PM EDT

Alumis (ALMS) Current Assets (2023 - 2026)

Updated

Alumis (ALMS) recorded Current Assets of $514.08 million in Q2 2026, down 0.7% from $517.56 million a year earlier.

Analysis

Alumis (ALMS) Current Assets (2023 - 2026) Analysis & Trends

At the end of FY2025, Alumis reported Current Assets of $318.23 million, up 3.9% from FY2024.

  • Across earlier years, Current Assets came in at $306.19 million in FY2024 (+473.8%) and $53.36 million in FY2023.
  • Quarterly Current Assets has ranged from $53.36 million in Q4 2023 to $517.56 million in Q2 2025 over the past five years.
  • On a year-over-year basis, Current Assets rose in four of the last five quarters, with growth averaging 122.3%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Alumis 891.03 Mn -783.81 Mn - 514.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 514.08 Mn
Dec 31, 2025 318.23 Mn
Sep 30, 2025 393.29 Mn
Jun 30, 2025 517.56 Mn
Mar 31, 2025 225.53 Mn
Dec 31, 2024 306.19 Mn
Sep 30, 2024 377.35 Mn
Jun 30, 2024 224.86 Mn
Dec 31, 2023 53.36 Mn
API Access

Alumis Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=ALMS&period=max&api_key=YOUR_API_KEY